SCHEMBL46095

SCHEMBL46095

CC1CC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12675735 1.00
SCHEMBL12085144 1.00
SCHEMBL12473717 1.00
SCHEMBL12675725 1.00
SCHEMBL684418 1.00
SCHEMBL45864 1.00
SCHEMBL5586361 1.00
SCHEMBL5586362 1.00
Ammonia Solution, Strong SCHEMBL27563464 0.95
Ammonia Solution, Strong SCHEMBL28088729 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12391802-B2 Method of forming semicrystalline polyetherimide, and polyetherimide-containing composition SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2025-08-19 US disclosed
US-20250145592-A1 COMPOUNDS, COMPOSITIONS, AND METHODS TENVIE THERAPEUTICS, INC. 2025-05-08 US disclosed
EP-4479054-A1 COMPOUNDS, COMPOSITIONS, AND METHODS Nico Therapeutics, Inc. (US) 2024-12-25 EP disclosed
WO-2024149282-A1 MODIFIED MULTI-SEGMENTED ANTISENSE OLIGONUCLEOTIDES FOR USE AUSPERBIO THERAPEUTICS INC. (US) 2024-07-18 WO disclosed
US-20240208912-A1 MTA-Cooperative PRMT5 Inhibitors MIRATI THERAPEUTICS INC (US) 2024-06-27 US disclosed
EP-4304720-A1 MTA-COOPERATIVE PRMT5 INHIBITORS Mirati Therapeutics, Inc. (US) 2024-01-17 EP disclosed
EP-4269119-A1 COLOR DEVELOPER, HEAT-SENSITIVE RECORDING MATERIAL, AND COATING MATERIAL FOR HEAT-SENSITIVE RECORDING LAYERS Sanko Co., Ltd. (JP) 2023-11-01 EP disclosed
US-20230331663-A1 SMALL MOLECULE NICOTINAMIDE ADENINE DINUCLEOTIDE MODULATORS THE CLEVELAND CLINIC FOUNDATION 2023-10-19 US disclosed
CN-116891540-A Alginic acid derivatives with non-steroidal anti-inflammatory compounds attached thereto 持田制药株式会社 2023-10-17 CN disclosed
WO-2023158708-A1 COMPOUNDS, COMPOSITIONS, AND METHODS DENALI THERAPEUTICS INC. (US) 2023-08-24 WO disclosed
US-6382537-B1 USING ALKALI METAL, ALKALINE-EARTH METAL, ALUMINUM OR IRON AS REDUCING AGENT AND ACTIVATED HYDROGEN BIRKE VOLKER (DE) 2002-05-07 US disclosed
WO-2002018319-A1 PROCESS FOR MAKING N-ARYL-ANTHRANILIC ACIDS AND THEIR DERIVATIVES WARNER-LAMBERT COMPANY LLC (US) 2002-03-07 WO disclosed
CN-1034932-C Herbicides RHONE POULENC AGRICULTURE (GB) 1997-05-21 CN disclosed
CN-1079767-A Water-proof refractory building gelatin material DONG XUECHENG (CN) 1993-12-22 CN disclosed
CN-1066843-A Weedicide RHONE POULENC AGRICULTURE (GB) 1992-12-09 CN disclosed
CN-1038156-A A kind of method of polycarbonate membrane of dry water-wet DOW CHEMICAL CO (US) 1989-12-20 CN disclosed
EP-0093010-B1 ALPHA-HYDROXYETHYLPHOSPHINATES, AND THEIR PRODUCTION AND USE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1986-06-11 EP disclosed
US-4554111-A α-Hydroxyethylphosphinates, and their production and use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-11-19 US disclosed
US-4544652-A α-Hydroxyethylphosphinates, and their use as fungicides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-10-01 US disclosed
EP-0093010-A2 Alpha-hydroxyethylphosphinates, and their production and use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1983-11-02 EP disclosed